De novo daptomycin-nonsusceptible enterococcal infections

Emerging Infectious Diseases

Volumn 18, Issue 4, 2012, Pages 674-676

  Kelesidis, Theodoros ^a   Humphries, Romney ^a   Uslan, Daniel Z ^a   Pegues, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; GENTAMICIN; LINEZOLID; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; STREPTOMYCIN; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 84858642612     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1804.110932     Document Type: Article

References (12)

1. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011;52:228-34. http://dx.doi.org/10.1093/cid/ciq113
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-first supplement. Wayne (PA): The Institute; 2011.
3. Clinical and Laboratory Standards Institute. Methods for dilution in antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 8th ed. Wayne (PA): The Institute; 2009.
4. Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother. 2009;53:4264-9. http://dx.doi.org/10.1128/AAC.00431-09
5. Kelesidis T. Comment on: successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J Antimicrob Chemother. 2012;67:515-6. http://dx.doi.org/10.1093/jac/dkr465
6. Lesho EP, Wortmann GW, Craft D, Moran KA. De novo daptomycin nonsusceptibility in a clinical isolate. J Clin Microbiol. 2006;44:673. http://dx.doi.org/10.1128/JCM.44.2.673.2006
7. Fraher MH, Corcoran GD, Creagh S, Feeney E. Daptomycinresistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin. J Hosp Infect. 2007;65:376-8. http://dx.doi.org/10.1016/j.jhin.2007.01.002
8. Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS. Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother. 2011;55:3345-56. http://dx.doi.org/10.1128/AAC.00207-11
9. Zhang J, Wall SK, Xu L, Ebner PD. Contamination rates and antimicrobial resistance in bacteria isolated from "grass-fed" labeled beef products. Foodborne Pathog Dis. 2010;7:1331-6. http://dx.doi.org/10.1089/fpd.2010.0562
10. Lester CH, Frimodt-Moller N, Sorensen TL, Monnet DL, Hammerum AM. In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother. 2006;50:596-9. http://dx.doi.org/10.1128/AAC.50.2.596-599.2006
11. Smith DL, Harris AD, Johnson JA, Silbergeld EK, Morris JG Jr. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci U S A. 2002;99:6434-9. http://dx.doi.org/10.1073/pnas.082188899
12. Waters AE, Contente-Cuomo T, Buchhagen J, Liu CM, Watson L, Pearce K, et al. Multidrug-resistant Staphylococcus aureus in US meat and poultry. Clin Infect Dis. 2011;52:1227-30. http://dx.doi. org/10.1093/cid/cir181